ATRC vs NDAQ · rev $294.9M vs P/E 41, rev $2.53B
AtriCure Inc (ATRC) versus Nasdaq Inc (NDAQ) — a side-by-side from cached financials, not a winner call.
AtriCure Inc (ATRC) is a medical instruments & supplies company listed on US.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Latest reported ATRC revenue for 2026-06-30 was $294.9M. Net income was $9.1M. ATRC currently screens at market cap $1.37B.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
ATRC currently screens at market cap $1.37B. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Not investment advice. Open the ATRC and NDAQ stock pages for the full models.
Not investment advice.